Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Severe acute respiratory syndrome coronavirus 2 is a recently discovered pathogen responsible of coronavirus disease 2019 (COVID-19). The immunological changes associated with this infection are largely unknown.
Methods
We evaluated the peripheral blood mononuclear cells profile of 63 patients with COVID-19 at diagnosis. We also assessed the presence of association with inflammatory biomarkers and the 28-day mortality.
Results
Lymphocytopenia was present in 51 of 63 (80.9%) patients, with a median value of 720 lymphocytes/µl (IQR 520-1,135). This reduction was mirrored also on CD8+ (128 cells/µl, IQR 55-215), natural killer (67 cells/µl, IQR 35–158) and natural killer T (31 cells/µl, IQR 11–78) cells. Monocytes were preserved in total number but displayed among them a subpopulation with a higher forward and side scatter properties, composed mainly of cells with a reduced expression of both CD14 and HLA-DR. Patients who died in the 28 days from admission (N=10, 15.9%), when compared to those who did not, displayed lower mean values of CD3+ (337.4 cells/µl vs 585.9 cells/µl; p=0.028) and CD4+ cells (232.2 cells/µl vs 381.1 cells/µl; p=0.042) and an higher percentage of CD8+/CD38+/HLA-DR+ lymphocytes (13.5% vs 7.6%; p=0.026).
Discussion
The early phases of COVID-19 are characterized by lymphocytopenia, predominance of Th2-like lymphocytes and monocytes with altered immune profile, which include atypical mononuclear cells.
Article activity feed
-
SciScore for 10.1101/2020.05.01.20087080: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: The study was approved by the Ethical Committee Milano Area 2 (#358_2020) and was conducted in accordance with the Helsinki Declaration Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources , RNA extraction with STARMag Universal Universal Cartridge kit on Nimbus instrument (Hamilton, Agrate Brianza, Italy) and amplification with Allplex® 2019-nCoV assay, while the second employed a GeneFinder® COVID-19 Plus RealAmp Kit (OSANG Healthcare, Anyangcheondong-ro, Dongan-gu, Anyang-si, Gyeonggi-do, Korea) on ELITech InGenius® instrument … SciScore for 10.1101/2020.05.01.20087080: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: The study was approved by the Ethical Committee Milano Area 2 (#358_2020) and was conducted in accordance with the Helsinki Declaration Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources , RNA extraction with STARMag Universal Universal Cartridge kit on Nimbus instrument (Hamilton, Agrate Brianza, Italy) and amplification with Allplex® 2019-nCoV assay, while the second employed a GeneFinder® COVID-19 Plus RealAmp Kit (OSANG Healthcare, Anyangcheondong-ro, Dongan-gu, Anyang-si, Gyeonggi-do, Korea) on ELITech InGenius® instrument (Torino, Italy). OSANG Healthcaresuggested: NoneFor each tube we set a stopping gate criterion of 50,000 events in the lymphocyte gate, forward scatter (FSC) versus side scatter (SSC), and the data were analysed using FACSSuite and FlowJo softwares (BD Biosciences). FlowJosuggested: (FlowJo, RRID:SCR_008520)All the analysis was performed with GraphPad Prism 8 (GraphPad Inc, USA). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:At the same time, we acknowledge that our research has limitations. First, it is a single centre study, conducted on a small number of patients. Second, it involved only patients diagnosed in hospital, therefore with a severe disease. Third, we did not investigate the presence and the features of immune cells at alveolar level, where most of COVID-19’s immunopathology occurs. To overcome this problem, we are collecting and analysing both PBMC and bronchoalveolar lavage fluid samples of COVID-19 patients. Overall, based on our results, we can hypothesize that COVID-19 causes a reduction of the lymphocyte populations, especially the cytotoxic lymphocytes, thus affecting both the innate and adaptive immunity. The diminished number of CTLs, supported by the elevated levels of cytokines such as IL-6, is probably associated with a decrease in global cytotoxic activity, which in turn can lead to a failure in the removal of the triggering antigens and therefore can elicit an overstimulation of the immune system. Monocytes, considered the crucial players in the pathogenesis of lung damage caused by the cytokines storm, showed substantial phenotypical alterations already in the early phase of the disease. The mechanism leading to monocytes alteration is unclear, but a direct viral role can be suspected. Indeed, Zhang et al.(Zhang et al., 2020) showed how monocytes express ACE2, the entry receptor of SARS-CoV-2, and it has been reported how other viral infections (influenza A virus, vac...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-
SciScore for 10.1101/2020.05.01.20087080: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement The study was approved by the Ethical Committee Milano Area 2 (#358_2020) and was conducted in accordance with the Helsinki Declaration. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources The first one consisted in Seegene Inc reagents (Seoul, Korea), RNA extraction with STARMag Universal Universal Cartridge kit on Nimbus instrument (Hamilton, Agrate Brianza, Italy) and amplification with Allplex® 2019-nCoV assay, while the second employed a GeneFinder® COVID-19 Plus RealAmp Kit (OSANG Healthcare, Anyangcheondong-ro, … SciScore for 10.1101/2020.05.01.20087080: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement The study was approved by the Ethical Committee Milano Area 2 (#358_2020) and was conducted in accordance with the Helsinki Declaration. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources The first one consisted in Seegene Inc reagents (Seoul, Korea), RNA extraction with STARMag Universal Universal Cartridge kit on Nimbus instrument (Hamilton, Agrate Brianza, Italy) and amplification with Allplex® 2019-nCoV assay, while the second employed a GeneFinder® COVID-19 Plus RealAmp Kit (OSANG Healthcare, Anyangcheondong-ro, Dongan-gu, Anyang-si, Gyeonggi-do, Korea) on ELITech InGenius® instrument (Torino, Italy). OSANG Healthcaresuggested: NoneFor each tube we set a stopping gate criterion of 50,000 events in the lymphocyte gate, forward scatter (FSC) versus side scatter (SSC), and the data were analysed using FACSSuite and FlowJo softwares (BD Biosciences). FlowJosuggested: (FlowJo, SCR_008520)All the analysis was performed with GraphPad Prism 8 (GraphPad Inc, USA). GraphPad Prismsuggested: (GraphPad Prism, SCR_002798)<div style="margin-bottom:8px"> <div><b>GraphPad</b></div> <div>suggested: (GraphPad Prism, <a href="https://scicrunch.org/resources/Any/search?q=SCR_002798">SCR_002798</a>)</div> </div> </td></tr></table>
Results from OddPub: We did not find a statement about open data. We also did not find a statement about open code. Researchers are encouraged to share open data when possible (see Nature blog).
About SciScore
SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore is not a substitute for expert review. SciScore checks for the presence and correctness of RRIDs (research resource identifiers) in the manuscript, and detects sentences that appear to be missing RRIDs. SciScore also checks to make sure that rigor criteria are addressed by authors. It does this by detecting sentences that discuss criteria such as blinding or power analysis. SciScore does not guarantee that the rigor criteria that it detects are appropriate for the particular study. Instead it assists authors, editors, and reviewers by drawing attention to sections of the manuscript that contain or should contain various rigor criteria and key resources. For details on the results shown here, including references cited, please follow this link.
-